SKELREGEN
SkelRegen is a new approach to musculoskeletal care appears to be on the horizon with the recent formation of a company, SkelRegen, aiming to regenerate human bone and other skeletal tissue.
Similar Organizations
Y2X Life Sciences
Y2X Life Sciences develops and creates improvement on disinfectants to prevent transmission of disease.
More informations about "SkelRegen"
SkelRegen - Crunchbase Company Profile & Funding
Organization. SkelRegen . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... SkelRegen is a new approach to musculoskeletal care appears โฆSee details»
Skelregen Company Profile 2024: Valuation, Funding & Investors
Skelregen General Information Description. Developer of patient-specific bone implants intended for maxillofacial reconstruction. The company utilizes 3D printing technology to create โฆSee details»
SkelRegen Company Profile | Management and Employees List
SkelRegen, LLC is the first company to identify not one, but multiple small molecules that are osteoinductive and target different aspects of the musculoskeletal tissue formation pathway. โฆSee details»
Stephen R. La Neve, Founder & CEO - Musculoskeletal New โฆ
SkelRegen is the first company to identify multiple osteoinductive small molecule families that leverage repurposed drugs and novel chemical entities; are delivered on a collagen sponge to โฆSee details»
iTIC Incubator - IIT Hyderabad
SkelRegen is trying to fulfill the huge demand for biomaterial supporting natural bone growth with self-degradation property to avoid multiple surgeries and adequate mechanical strength. Value โฆSee details»
SkelRegen - Drug pipelines, Patents, Clinical trials - Synapse
Explore SkelRegen with its drug pipeline, therapeutic area, technology platform, .See details»
Georgia Research Alliance - GRA
SkelRegen is a drug discovery company focused on ways to enhance bone and cartilage formation and accelerate the healing of bone fractures. The company currently has three drug โฆSee details»
SkelRegen - Overview, News & Competitors | ZoomInfo.com
SkelRegen, LLC is the first company to identify not one, but multiple small molecules that are osteoinductive and target different aspects of the musculoskeletal tissue formation pathway. โฆSee details»
SkelRegen - Tech Stack, Apps, Patents & Trademarks - Crunchbase
SkelRegen focus on newly identified small molecules that target different aspects of the skeletal tissue formation pathway.See details»
SkelRegen - Crunchbase
Organization. SkelRegen . Connect to CRM . Save . Summary People Signals & News Similar Companies. Similar Companies. Edit Similar Companies Section. Companies like SkelRegen โฆSee details»
New Company, SkelRegen, LLC, Aims to Regenerate Skeletal Tissue
Oct 8, 2012 SkelRegen results from a collaboration between Scott D. Boden, MD, Chief Medical Officer at the Emory University Orthopaedic & Spine Hospital and Professor of Orthopaedics, โฆSee details»
SkelRegen's new CEO has been there since company's founding.
Jan 1, 2014 SkelRegen LLC has a new leader. The West Chester, Pa.-based company has appointed Todd F. La Neve, J.D., as CEO, replacing Stephen R. La Neve, who will serve as co โฆSee details»
New Company Aims to Regenerate Skeletal Tissue - CNBC
Oct 5, 2012 The company, called SkelRegen, LLC, has already identified several compounds that it believes could transform musculoskeletal care. WEST CHESTER, Pa.---- A new โฆSee details»
SkelRegen Forms With Focus on Musculoskeletal Care
A new company โ SkelRegen โ has formed to create musculoskeletal solutions in orthopedics, according to a Herald report. SkelRegen Forms With Focus on Musculoskeletal Care Becker's โฆSee details»
SkelRegen Continues to Gain Traction in Skeletal Tissue ... - BioSpace
Apr 2, 2013 SkelRegen is the first company to focus on newly identified small molecules that target different aspects of the skeletal tissue formation pathway. The results of the study โฆSee details»
SkelRegen Continues to Gain Traction in Skeletal Tissue โฆ
Apr 2, 2013 SkelRegen is the first company to focus on newly identified small molecules that target different aspects of the skeletal tissue formation pathway. The results of the study โฆSee details»
SkelRegen Continues to Gain Traction in Skeletal Tissue โฆ
WEST CHESTER, Pa., April 2, 2013 /PRNewswire/ -- SkelRegen, LLC continues to lead the way in musculoskeletal tissue regeneration. SkelRegen Co-Founder and Chief Medical, Science & โฆSee details»
Former Medtronic presidentโs new orthopaedic startup uses small ...
Oct 9, 2012 A former Medtronic president and the director of Emory University Orthopaedics and Spine Center have launched a biotechnology company to develop molecular compounds. The โฆSee details»
SKELREGEN PRIVATE LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SKELREGEN PRIVATE LIMITED of Hyderabad, Telangana. Get the latest business insights from Dun & โฆSee details»